Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lengerke C" with an ORCID

Claudia Lengerke
Universität Basel Departement Biomedizin
79
Publications
4,167
Citations
View profile

Search results

1-25 of 155 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate.
Schaefer T, Mittal N, Wang H, Ataman M, Candido S, Lötscher J, Velychko S, Tintignac L, Bock T, Börsch A, Baßler J, Rao TN, Zmajkovic J, Roffeis S, Löliger J, Jacob F, Dumlin A, Schürch C, Schmidt A, [...] Lengerke C
Cell Rep, 43(10):114807, 03 Oct 2024
Cited by: 0 articles | PMID: 39368083
Add to export list
Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation.
Beer SA, Möhle R, Tabatabai G, Merle DA, Ernemann U, Richter V, Lengerke C
Bone Marrow Transplant, 59(11):1506-1512, 09 Aug 2024
Cited by: 0 articles | PMID: 39122834 | PMCID: PMC11530371
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.
Atar D, Ruoff L, Mast AS, Krost S, Moustafa-Oglou M, Scheuermann S, Kristmann B, Feige M, Canak A, Wolsing K, Schlager L, Schilbach K, Zekri L, Ebinger M, Nixdorf D, Subklewe M, Schulte J, Lengerke C, Jeremias I, [...] Seitz CM
Leukemia, 38(10):2183-2195, 03 Aug 2024
Cited by: 0 articles | PMID: 39095503 | PMCID: PMC11436361
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Future of CAR T Therapeutics to Treat Autoimmune Disorders.
Pecher AC, Hensen L, Lengerke C, Henes J
Mol Diagn Ther, 28(5):593-600, 30 Jul 2024
Cited by: 0 articles | PMID: 39078456 | PMCID: PMC11349844
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.
Schroeder JC, Mix L, Faustmann P, Weller JF, Fehn A, Phely L, Riedel A, Vogel W, Faul C, Lengerke C, Bethge WA
Bone Marrow Transplant, 59(9):1332-1334, 09 Jul 2024
Cited by: 0 articles | PMID: 38982155 | PMCID: PMC11368806
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity.
Wesle A, Moraes Ribeiro E, Schairer R, Keppeler H, Korkmaz F, Radszuweit P, Bieber K, Lengerke C, Schneidawind D, Schneidawind C
Cytotherapy, S1465-3249(24)00824-7, 10 Aug 2024
Cited by: 0 articles | PMID: 39269404
Add to export list
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
Rücker FG, Corbacioglu A, Krzykalla J, Cocciardi S, Lengerke C, Germing U, Wulf G, Samra MA, Teichmann LL, Lübbert M, Kühn MWM, Bentz M, Westermann J, Bullinger L, Gaidzik VI, Meid A, Aicher S, Stegelmann F, Weber D, [...] German‐Austrian Acute Myeloid Leukemia Study Group (AMLSG)
Hemasphere, 8(7):e123, 15 Jul 2024
Cited by: 1 article | PMID: 39011127 | PMCID: PMC11247273
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.
Maier CP, Klose C, Seitz CM, Heubach F, Döring M, Meisel R, Schuster F, Gruhn B, Keller F, Rabsteyn A, Arendt AM, Amorelli G, Eichholz T, Feuchtinger T, Martinius H, Nierkens S, Teltschik R, Schulte JH, Lengerke C, [...] Lang P
Blood Adv, 8(9):2160-2171, 01 May 2024
Cited by: 1 article | PMID: 38290133
Add to export list
Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.
Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P, Bethge W, Lengerke C, Vogel W
Transpl Infect Dis, 26(4):e14296, 03 Jun 2024
Cited by: 2 articles | PMID: 38830809
Add to export list
Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia.
Phely L, Hensen L, Faul C, Ruff CA, Schneider D, Bethge WA, Lengerke C
JAMA Oncol, 10(6):821-824, 01 Jun 2024
Cited by: 0 articles | PMID: 38635232 | PMCID: PMC11190796
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemia.
Beer SA, Bethge W, Faul C, Lengerke C, Vogel W
EJHaem, 5(3):620-623, 15 May 2024
Cited by: 0 articles | PMID: 38895070 | PMCID: PMC11182411
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential
Görsch E, Arnone M, Klimiankou M, Weller J, Rudat S, Klein G, Lengerke C
bioRxiv, 01 Apr 2024
Cited by: 0 articles | PPR: PPR830814
Add to export list Preprint
Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm - collected cases from a single center and case reports.
Faustmann P, Schroeder JC, Mix L, Harland L, Riedel A, Vogel W, Lengerke C, Wirths S
Front Oncol, 14:1384172, 11 Apr 2024
Cited by: 1 article | PMID: 38665943 | PMCID: PMC11043520
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M, Ritter MU, Mir P, Dannenmann B, Kaufmann MM, Arreba-Tutusaus P, Xu Y, Borbaran-Bravo N, Klimiankou M, Lengerke C, Zeidler C, Cathomen T, Welte K, Skokowa J
Mol Ther, 32(6):1628-1642, 30 Mar 2024
Cited by: 1 article | PMID: 38556793
Add to export list
Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series.
Riedel A, Faul C, Reuss K, Schröder JC, Lang PJ, Lengerke C, Weissert N, Hengel H, Gröschel S, Schoels L, Bethge WA
Blood Adv, 8(6):1504-1508, 01 Mar 2024
Cited by: 0 articles | PMID: 38330194 | PMCID: PMC10966161
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC, Klein R, Koetter I, Wagner M, Vogel W, Wirths S, Lengerke C, Henes JC
Arthritis Res Ther, 26(1):75, 20 Mar 2024
Cited by: 0 articles | PMID: 38509633 | PMCID: PMC10953154
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype.
Schumacher M, Beer S, Moraes Ribeiro E, Korkmaz F, Keppeler H, Fitzel R, Erkner E, Radszuweit P, Lengerke C, Schneidawind C, Hoefert S, Mauz PS, Schneidawind D
Front Oncol, 14:1333640, 07 Mar 2024
Cited by: 1 article | PMID: 38515578 | PMCID: PMC10955476
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.
Moraes Ribeiro E, Secker KA, Nitulescu AM, Schairer R, Keppeler H, Wesle A, Schmid H, Schmitt A, Neuber B, Chmiest D, Podavini S, Märklin M, Klimovich B, Schmitt M, Korkmaz F, Lengerke C, Schneidawind C, Schneidawind D
J Immunother Cancer, 12(1):e007829, 31 Jan 2024
Cited by: 0 articles | PMID: 38296597 | PMCID: PMC10831439
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT
Maier C, Klose C, Seitz C, Heubach F, Döring M, Meisel R, Schuster F, Gruhn B, Keller F, Rabsteyn A, Arendt A, Amorelli G, Eichholz T, Feuchtinger T, Martinius H, Nierkens S, Teltschik R, Schulte J, Lengerke C, [...] Lang P
Blood Adv, 8(9):2160-2171, 01 Feb 2024
Cited by: 0 articles | PMCID: PMC11068504
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Weller JF, Lengerke C, Finke J, Schetelig J, Platzbecker U, Einsele H, Schroeder T, Faul C, Stelljes M, Dreger P, Blau IW, Wulf G, Tischer J, Scheid C, Elmaagacli A, Neidlinger H, Flossdorf S, Bornhäuser M, Bethge W, [...] Christopeit M
Haematologica, 109(2):431-443, 01 Feb 2024
Cited by: 2 articles | PMID: 37646665
Add to export list
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy-a case report and literature review.
Hoffmann E, Böke S, De-Colle C, Lengerke C, Niyazi KM, Gani C
Strahlenther Onkol, 200(10):908-915, 29 Jan 2024
Cited by: 0 articles | PMID: 38285172 | PMCID: PMC11442554
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Rational Combinatorial Targeting by Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)
Atar DB, Ruoff L, Mast A, Krost S, Moustafa-Oglou M, Scheuermann S, Kristmann B, Feige M, Canak A, Wolsing K, Schilbach K, Zekri L, Ebinger M, Nixdorf D, Subklewe M, Schulte J, Lengerke C, Werchau N, Mittelstaet J, [...] Seitz CM
Research Square, 29 Nov 2023
Cited by: 0 articles | PPR: PPR765940
Add to export list Preprint v1
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
Erkner E, Hentrich T, Schairer R, Fitzel R, Secker-Grob KA, Jeong J, Keppeler H, Korkmaz F, Schulze-Hentrich JM, Lengerke C, Schneidawind D, Schneidawind C
Oncogene, 43(4):281-293, 29 Nov 2023
Cited by: 2 articles | PMID: 38030791 | PMCID: PMC10798886
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Tuning of granulopoietic signaling byde novodesigned agonists
Ullrich T, Pollmann C, Ritter M, Haaf J, Aghaallaei N, Tesakov I, El-Riz M, Maksymenko K, Hatskovska V, Kandabarau S, Klimiankou M, Lengerke C, Welte K, Hernandez-Alvarez B, Müller P, Lupas A, Piehler J, Skokowa J, ElGamacy M
bioRxiv, 25 Nov 2023
Cited by: 0 articles | PPR: PPR764874
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Nelde A, Schuster H, Heitmann JS, Bauer J, Maringer Y, Zwick M, Volkmer JP, Chen JY, Stanger AMP, Lehmann A, Appiah B, Märklin M, Rücker-Braun E, Salih HR, Roerden M, Schroeder SM, Häring MF, Schlosser A, Schetelig J, [...] Walz JS
Blood Cancer Discov, 4(6):468-489, 01 Nov 2023
Cited by: 7 articles | PMID: 37847741 | PMCID: PMC10618727
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 155 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lengerke C" with an ORCID

Search results

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate.

Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation.

Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.

The Future of CAR T Therapeutics to Treat Autoimmune Disorders.

Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.

CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity.

Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).

Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.

Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.

Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia.

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemia.

Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm - collected cases from a single center and case reports.

CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.

Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series.

Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.

Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype.

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT

Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.

Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy-a case report and literature review.

Rational Combinatorial Targeting by Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)

The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.

Tuning of granulopoietic signaling byde novodesigned agonists

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Partnerships & funding

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lengerke C" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Lengerke C" with an ORCID